nodes	percent_of_prediction	percent_of_DWPC	metapath
Amcinonide—ANXA1—lung cancer	0.844	1	CbGaD
Amcinonide—Pustule—Erlotinib—lung cancer	0.00697	0.176	CcSEcCtD
Amcinonide—ANXA1—mammary gland—lung cancer	0.0055	0.167	CbGeAlD
Amcinonide—ANXA1—respiratory system—lung cancer	0.00366	0.111	CbGeAlD
Amcinonide—ANXA1—epithelium—lung cancer	0.00306	0.0928	CbGeAlD
Amcinonide—ANXA1—bronchus—lung cancer	0.00301	0.0914	CbGeAlD
Amcinonide—Dermatitis acneiform—Erlotinib—lung cancer	0.00276	0.0698	CcSEcCtD
Amcinonide—ANXA1—trachea—lung cancer	0.00271	0.082	CbGeAlD
Amcinonide—ANXA1—cardiac atrium—lung cancer	0.00254	0.0771	CbGeAlD
Amcinonide—ANXA1—bone marrow—lung cancer	0.00215	0.0651	CbGeAlD
Amcinonide—Rash pustular—Gefitinib—lung cancer	0.00198	0.05	CcSEcCtD
Amcinonide—ANXA1—lung—lung cancer	0.00195	0.0589	CbGeAlD
Amcinonide—Tenderness—Gefitinib—lung cancer	0.00181	0.0457	CcSEcCtD
Amcinonide—Folliculitis—Erlotinib—lung cancer	0.0015	0.0379	CcSEcCtD
Amcinonide—Telangiectasia—Methotrexate—lung cancer	0.00142	0.036	CcSEcCtD
Amcinonide—ANXA1—lymph node—lung cancer	0.00133	0.0403	CbGeAlD
Amcinonide—NR3C1—respiratory system—lung cancer	0.00127	0.0386	CbGeAlD
Amcinonide—Rash pustular—Erlotinib—lung cancer	0.00118	0.0299	CcSEcCtD
Amcinonide—Tenderness—Erlotinib—lung cancer	0.00108	0.0273	CcSEcCtD
Amcinonide—NR3C1—epithelium—lung cancer	0.00106	0.0322	CbGeAlD
Amcinonide—NR3C1—bronchus—lung cancer	0.00105	0.0317	CbGeAlD
Amcinonide—Secondary infection—Doxorubicin—lung cancer	0.000988	0.025	CcSEcCtD
Amcinonide—NR3C1—trachea—lung cancer	0.00094	0.0285	CbGeAlD
Amcinonide—NR3C1—cardiac atrium—lung cancer	0.000883	0.0268	CbGeAlD
Amcinonide—Folliculitis—Paclitaxel—lung cancer	0.000873	0.0221	CcSEcCtD
Amcinonide—Leukoderma—Methotrexate—lung cancer	0.000789	0.0199	CcSEcCtD
Amcinonide—Tenderness—Gemcitabine—lung cancer	0.000751	0.019	CcSEcCtD
Amcinonide—NR3C1—bone marrow—lung cancer	0.000746	0.0226	CbGeAlD
Amcinonide—Tenderness—Cisplatin—lung cancer	0.0007	0.0177	CcSEcCtD
Amcinonide—Leukoderma—Doxorubicin—lung cancer	0.000683	0.0173	CcSEcCtD
Amcinonide—NR3C1—lung—lung cancer	0.000676	0.0205	CbGeAlD
Amcinonide—Tenderness—Paclitaxel—lung cancer	0.000629	0.0159	CcSEcCtD
Amcinonide—Infection—Crizotinib—lung cancer	0.000616	0.0156	CcSEcCtD
Amcinonide—Infection—Pemetrexed—lung cancer	0.000563	0.0142	CcSEcCtD
Amcinonide—Infection—Gefitinib—lung cancer	0.00056	0.0141	CcSEcCtD
Amcinonide—Folliculitis—Methotrexate—lung cancer	0.000533	0.0135	CcSEcCtD
Amcinonide—Pain—Pemetrexed—lung cancer	0.000485	0.0122	CcSEcCtD
Amcinonide—Pain—Gefitinib—lung cancer	0.000482	0.0122	CcSEcCtD
Amcinonide—NR3C1—lymph node—lung cancer	0.000462	0.014	CbGeAlD
Amcinonide—Folliculitis—Doxorubicin—lung cancer	0.000462	0.0117	CcSEcCtD
Amcinonide—Infection—Teniposide—lung cancer	0.000456	0.0115	CcSEcCtD
Amcinonide—Dexamethasone—ANXA1—lung cancer	0.000414	0.197	CrCbGaD
Amcinonide—Pruritus—Pemetrexed—lung cancer	0.000401	0.0101	CcSEcCtD
Amcinonide—Pruritus—Gefitinib—lung cancer	0.000399	0.0101	CcSEcCtD
Amcinonide—Dermatitis—Crizotinib—lung cancer	0.000391	0.00987	CcSEcCtD
Amcinonide—Rash pustular—Doxorubicin—lung cancer	0.000364	0.0092	CcSEcCtD
Amcinonide—Stinging—Doxorubicin—lung cancer	0.000358	0.00906	CcSEcCtD
Amcinonide—Dermatitis—Pemetrexed—lung cancer	0.000357	0.00902	CcSEcCtD
Amcinonide—Dermatitis—Gefitinib—lung cancer	0.000355	0.00897	CcSEcCtD
Amcinonide—Infection—Topotecan—lung cancer	0.000338	0.00854	CcSEcCtD
Amcinonide—Infection—Erlotinib—lung cancer	0.000335	0.00845	CcSEcCtD
Amcinonide—Pruritus—Teniposide—lung cancer	0.000325	0.00821	CcSEcCtD
Amcinonide—Pain—Vinblastine—lung cancer	0.0003	0.00757	CcSEcCtD
Amcinonide—Pain—Topotecan—lung cancer	0.000291	0.00735	CcSEcCtD
Amcinonide—Dermatitis—Teniposide—lung cancer	0.000289	0.00731	CcSEcCtD
Amcinonide—Infection—Vinorelbine—lung cancer	0.000289	0.00731	CcSEcCtD
Amcinonide—Pain—Erlotinib—lung cancer	0.000288	0.00728	CcSEcCtD
Amcinonide—Dermatitis contact—Doxorubicin—lung cancer	0.000287	0.00725	CcSEcCtD
Amcinonide—Pain—Vinorelbine—lung cancer	0.000249	0.00629	CcSEcCtD
Amcinonide—Pruritus—Topotecan—lung cancer	0.000241	0.00608	CcSEcCtD
Amcinonide—Infection—Irinotecan—lung cancer	0.000239	0.00603	CcSEcCtD
Amcinonide—Pruritus—Erlotinib—lung cancer	0.000238	0.00602	CcSEcCtD
Amcinonide—Clobetasol propionate—CYP1A1—lung cancer	0.000238	0.113	CrCbGaD
Amcinonide—Infection—Gemcitabine—lung cancer	0.000232	0.00587	CcSEcCtD
Amcinonide—Prednisolone—CYP2A6—lung cancer	0.000223	0.106	CrCbGaD
Amcinonide—Infection—Cisplatin—lung cancer	0.000217	0.00547	CcSEcCtD
Amcinonide—Dermatitis—Topotecan—lung cancer	0.000214	0.00542	CcSEcCtD
Amcinonide—Dermatitis—Erlotinib—lung cancer	0.000212	0.00536	CcSEcCtD
Amcinonide—Pruritus—Vinorelbine—lung cancer	0.000206	0.0052	CcSEcCtD
Amcinonide—Pain—Irinotecan—lung cancer	0.000205	0.00519	CcSEcCtD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6R—lung cancer	0.000203	0.00248	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—GRM8—lung cancer	0.000202	0.00248	CbGpPWpGaD
Amcinonide—Pain—Gemcitabine—lung cancer	0.0002	0.00505	CcSEcCtD
Amcinonide—ANXA1—Spinal Cord Injury—MAPK3—lung cancer	0.000199	0.00245	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—CCND1—lung cancer	0.000199	0.00244	CbGpPWpGaD
Amcinonide—Infection—Etoposide—lung cancer	0.000198	0.00501	CcSEcCtD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—JUN—lung cancer	0.000198	0.00243	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of Androgen receptor activity—CREBBP—lung cancer	0.000196	0.0024	CbGpPWpGaD
Amcinonide—Infection—Paclitaxel—lung cancer	0.000195	0.00492	CcSEcCtD
Amcinonide—ANXA1—Spinal Cord Injury—MYC—lung cancer	0.000194	0.00238	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—MMP1—lung cancer	0.000194	0.00238	CbGpPWpGaD
Amcinonide—ANXA1—G alpha (i) signalling events—POMC—lung cancer	0.000193	0.00237	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—MAP2K1—lung cancer	0.000193	0.00237	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—HIF1A—lung cancer	0.000192	0.00236	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—PTEN—lung cancer	0.000192	0.00235	CbGpPWpGaD
Amcinonide—NR3C1—Circadian Clock—CREBBP—lung cancer	0.00019	0.00233	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—EGFR—lung cancer	0.00019	0.00233	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—MDM2—lung cancer	0.000189	0.00232	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—RAF1—lung cancer	0.000188	0.00231	CbGpPWpGaD
Amcinonide—Pain—Cisplatin—lung cancer	0.000186	0.00471	CcSEcCtD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—ERBB2—lung cancer	0.000186	0.00228	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—AXL—lung cancer	0.000186	0.00228	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—TF—lung cancer	0.000184	0.00226	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—GRP—lung cancer	0.000184	0.00225	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—OXTR—lung cancer	0.000184	0.00225	CbGpPWpGaD
Amcinonide—Dermatitis—Vinorelbine—lung cancer	0.000183	0.00463	CcSEcCtD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—EP300—lung cancer	0.000183	0.00224	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—PTGS2—lung cancer	0.000182	0.00223	CbGpPWpGaD
Amcinonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—EP300—lung cancer	0.000178	0.00218	CbGpPWpGaD
Amcinonide—ANXA1—Peptide ligand-binding receptors—CXCL8—lung cancer	0.000177	0.00218	CbGpPWpGaD
Amcinonide—NR3C1—Transcription factor regulation in adipogenesis—IL6—lung cancer	0.000177	0.00217	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—AVP—lung cancer	0.000176	0.00216	CbGpPWpGaD
Amcinonide—NR3C1—Endoderm Differentiation—APC—lung cancer	0.000173	0.00212	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—VEGFA—lung cancer	0.000173	0.00212	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—GNG11—lung cancer	0.000172	0.00211	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—lung cancer	0.000171	0.0021	CbGpPWpGaD
Amcinonide—Pain—Etoposide—lung cancer	0.000171	0.00432	CcSEcCtD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—MMP1—lung cancer	0.000171	0.00209	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—CASP3—lung cancer	0.000169	0.00207	CbGpPWpGaD
Amcinonide—Pain—Paclitaxel—lung cancer	0.000167	0.00423	CcSEcCtD
Amcinonide—ANXA1—Signaling by GPCR—OXTR—lung cancer	0.000167	0.00204	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—GRP—lung cancer	0.000167	0.00204	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of Androgen receptor activity—MDM2—lung cancer	0.000166	0.00204	CbGpPWpGaD
Amcinonide—Pruritus—Gemcitabine—lung cancer	0.000165	0.00418	CcSEcCtD
Amcinonide—Infection—Docetaxel—lung cancer	0.000165	0.00417	CcSEcCtD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—CCND1—lung cancer	0.000165	0.00202	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—JUN—lung cancer	0.000164	0.00201	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—TP53—lung cancer	0.000159	0.00195	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—MYC—lung cancer	0.000159	0.00195	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—CDKN1A—lung cancer	0.000159	0.00195	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—PTEN—lung cancer	0.000159	0.00195	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—GNG11—lung cancer	0.000156	0.00191	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—EGFR—lung cancer	0.000156	0.00191	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—ADCY1—lung cancer	0.000155	0.0019	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—POMC—lung cancer	0.000154	0.00189	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—EP300—lung cancer	0.000151	0.00186	CbGpPWpGaD
Amcinonide—Dermatitis—Irinotecan—lung cancer	0.000151	0.00382	CcSEcCtD
Amcinonide—ANXA1—G alpha (i) signalling events—CXCL8—lung cancer	0.00015	0.00184	CbGpPWpGaD
Amcinonide—Fluticasone furoate—ABCB1—lung cancer	0.000148	0.0701	CrCbGaD
Amcinonide—Dermatitis—Gemcitabine—lung cancer	0.000147	0.00372	CcSEcCtD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—SRC—lung cancer	0.000147	0.00181	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—KRAS—lung cancer	0.000147	0.0018	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—IL6—lung cancer	0.000146	0.00179	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of Androgen receptor activity—JUN—lung cancer	0.000145	0.00177	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—COL4A2—lung cancer	0.000144	0.00177	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—PTHLH—lung cancer	0.000144	0.00176	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—VEGFA—lung cancer	0.000143	0.00176	CbGpPWpGaD
Amcinonide—Pain—Docetaxel—lung cancer	0.000142	0.00359	CcSEcCtD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—POMC—lung cancer	0.000142	0.00174	CbGpPWpGaD
Amcinonide—Pruritus—Etoposide—lung cancer	0.000141	0.00357	CcSEcCtD
Amcinonide—ANXA1—Signaling Pathways—GIPR—lung cancer	0.000141	0.00173	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—ADCY1—lung cancer	0.00014	0.00172	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CREBBP—lung cancer	0.00014	0.00171	CbGpPWpGaD
Amcinonide—Pruritus—Paclitaxel—lung cancer	0.000139	0.0035	CcSEcCtD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—CREBBP—lung cancer	0.000138	0.0017	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—CDKN2A—lung cancer	0.000137	0.00169	CbGpPWpGaD
Amcinonide—Dermatitis—Cisplatin—lung cancer	0.000137	0.00347	CcSEcCtD
Amcinonide—ANXA1—Signaling by GPCR—PPP2R1B—lung cancer	0.000137	0.00168	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—MAPK3—lung cancer	0.000136	0.00166	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of Androgen receptor activity—EP300—lung cancer	0.000133	0.00164	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—MYC—lung cancer	0.000132	0.00162	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—SDC4—lung cancer	0.000131	0.00161	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—TP53—lung cancer	0.000131	0.0016	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—PTHLH—lung cancer	0.00013	0.0016	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of Androgen receptor activity—SRC—lung cancer	0.00013	0.00159	CbGpPWpGaD
Amcinonide—NR3C1—Circadian Clock—EP300—lung cancer	0.00013	0.00159	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—EGFR—lung cancer	0.000129	0.00158	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—lung cancer	0.000129	0.00158	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—DUSP3—lung cancer	0.000129	0.00158	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—APP—lung cancer	0.000128	0.00157	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—AVP—lung cancer	0.000128	0.00157	CbGpPWpGaD
Amcinonide—Dexamethasone—CYP2A6—lung cancer	0.000127	0.0603	CrCbGaD
Amcinonide—ANXA1—Signaling Pathways—RHEB—lung cancer	0.000126	0.00155	CbGpPWpGaD
Amcinonide—Dermatitis—Etoposide—lung cancer	0.000126	0.00318	CcSEcCtD
Amcinonide—NR3C1—AP-1 transcription factor network—CXCL8—lung cancer	0.000125	0.00153	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—lung cancer	0.000123	0.00151	CbGpPWpGaD
Amcinonide—Dermatitis—Paclitaxel—lung cancer	0.000123	0.00312	CcSEcCtD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—KRAS—lung cancer	0.000122	0.0015	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—HES1—lung cancer	0.000121	0.00148	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—IL10—lung cancer	0.00012	0.00147	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—GRM8—lung cancer	0.00012	0.00147	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—IL2—lung cancer	0.000119	0.00146	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—CXCL8—lung cancer	0.000119	0.00146	CbGpPWpGaD
Amcinonide—Infection—Methotrexate—lung cancer	0.000119	0.003	CcSEcCtD
Amcinonide—Pruritus—Docetaxel—lung cancer	0.000117	0.00297	CcSEcCtD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—lung cancer	0.000117	0.00144	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—MDM2—lung cancer	0.000117	0.00144	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—POMC—lung cancer	0.000117	0.00144	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—HIF1A—lung cancer	0.000117	0.00144	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—SKI—lung cancer	0.000117	0.00143	CbGpPWpGaD
Amcinonide—Triamcinolone—PTGS2—lung cancer	0.000117	0.0554	CrCbGaD
Amcinonide—ANXA1—Signaling by GPCR—APP—lung cancer	0.000116	0.00143	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—CCND1—lung cancer	0.000116	0.00142	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—SKI—lung cancer	0.000116	0.00142	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—JUN—lung cancer	0.000116	0.00142	CbGpPWpGaD
Amcinonide—ANXA1—G alpha (q) signalling events—PIK3CA—lung cancer	0.000114	0.0014	CbGpPWpGaD
Amcinonide—Dexamethasone—ABCG2—lung cancer	0.000114	0.0539	CrCbGaD
Amcinonide—NR3C1—AP-1 transcription factor network—MMP9—lung cancer	0.000113	0.00138	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—PTEN—lung cancer	0.000112	0.00137	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—PIK3CA—lung cancer	0.000112	0.00137	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—lung cancer	0.000111	0.00136	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—AKT1—lung cancer	0.00011	0.00135	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—lung cancer	0.00011	0.00135	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	0.000108	0.00133	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—EP300—lung cancer	0.000107	0.00131	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—IL2—lung cancer	0.000105	0.00129	CbGpPWpGaD
Amcinonide—Dermatitis—Docetaxel—lung cancer	0.000105	0.00264	CcSEcCtD
Amcinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—JUN—lung cancer	0.000103	0.00126	CbGpPWpGaD
Amcinonide—Infection—Doxorubicin—lung cancer	0.000103	0.0026	CcSEcCtD
Amcinonide—Pain—Methotrexate—lung cancer	0.000102	0.00258	CcSEcCtD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—JUN—lung cancer	0.000102	0.00125	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—lung cancer	0.000102	0.00125	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—EIF2B4—lung cancer	0.000101	0.00124	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—HIF1A—lung cancer	0.000101	0.00124	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PXN—lung cancer	0.000101	0.00123	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—lung cancer	9.99e-05	0.00123	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—AVP—lung cancer	9.96e-05	0.00122	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—lung cancer	9.89e-05	0.00121	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—AKR1C1—lung cancer	9.85e-05	0.00121	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—OXTR—lung cancer	9.85e-05	0.00121	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—GRP—lung cancer	9.85e-05	0.00121	CbGpPWpGaD
Amcinonide—Betamethasone—PTGS2—lung cancer	9.56e-05	0.0454	CrCbGaD
Amcinonide—NR3C1—Adipogenesis—RB1—lung cancer	9.53e-05	0.00117	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—EP300—lung cancer	9.51e-05	0.00117	CbGpPWpGaD
Amcinonide—Prednisone—ALB—lung cancer	9.43e-05	0.0448	CrCbGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—lung cancer	9.43e-05	0.00116	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—EP300—lung cancer	9.41e-05	0.00115	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—RARB—lung cancer	9.39e-05	0.00115	CbGpPWpGaD
Amcinonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—lung cancer	9.36e-05	0.00115	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—MYC—lung cancer	9.31e-05	0.00114	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—GNG11—lung cancer	9.22e-05	0.00113	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	9.15e-05	0.00112	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—NPPA—lung cancer	9.15e-05	0.00112	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—CXCL8—lung cancer	9.06e-05	0.00111	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—AVP—lung cancer	9.04e-05	0.00111	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—lung cancer	9.03e-05	0.00111	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—HNRNPA2B1—lung cancer	9.02e-05	0.00111	CbGpPWpGaD
Amcinonide—Dexamethasone—CYP2E1—lung cancer	9.02e-05	0.0428	CrCbGaD
Amcinonide—Prednisone—ABCB1—lung cancer	9e-05	0.0427	CrCbGaD
Amcinonide—Dexamethasone—CYP1A1—lung cancer	8.9e-05	0.0423	CrCbGaD
Amcinonide—Pain—Doxorubicin—lung cancer	8.86e-05	0.00224	CcSEcCtD
Amcinonide—ANXA1—Signaling Pathways—VEGFC—lung cancer	8.78e-05	0.00108	CbGpPWpGaD
Amcinonide—Pruritus—Methotrexate—lung cancer	8.46e-05	0.00214	CcSEcCtD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—MAPK3—lung cancer	8.44e-05	0.00103	CbGpPWpGaD
Amcinonide—Prednisolone—ABCB1—lung cancer	8.3e-05	0.0394	CrCbGaD
Amcinonide—ANXA1—Signaling Pathways—ADCY1—lung cancer	8.29e-05	0.00102	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—lung cancer	8.29e-05	0.00102	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—IL6R—lung cancer	8.28e-05	0.00102	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—CREBBP—lung cancer	8.26e-05	0.00101	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—KHSRP—lung cancer	8.25e-05	0.00101	CbGpPWpGaD
Amcinonide—Betamethasone—ABCB1—lung cancer	8.13e-05	0.0386	CrCbGaD
Amcinonide—ANXA1—Signaling Pathways—PPP2R1B—lung cancer	8.08e-05	0.000991	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—SMARCA4—lung cancer	8.08e-05	0.000991	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—HSPB1—lung cancer	7.8e-05	0.000956	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PTHLH—lung cancer	7.71e-05	0.000945	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—TP53—lung cancer	7.65e-05	0.000938	CbGpPWpGaD
Amcinonide—Dermatitis—Methotrexate—lung cancer	7.54e-05	0.0019	CcSEcCtD
Amcinonide—Pruritus—Doxorubicin—lung cancer	7.33e-05	0.00185	CcSEcCtD
Amcinonide—NR3C1—Gene Expression—EIF2B5—lung cancer	7.21e-05	0.000885	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—FLT1—lung cancer	7.02e-05	0.000861	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—IL6—lung cancer	7e-05	0.000858	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—PIK3CG—lung cancer	6.95e-05	0.000853	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—NOTCH3—lung cancer	6.94e-05	0.000851	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—NOTCH3—lung cancer	6.87e-05	0.000843	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—APP—lung cancer	6.87e-05	0.000843	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—CDKN1A—lung cancer	6.84e-05	0.000839	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—FGF9—lung cancer	6.81e-05	0.000836	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—TP53—lung cancer	6.74e-05	0.000826	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—POMC—lung cancer	6.62e-05	0.000812	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—JUNB—lung cancer	6.57e-05	0.000806	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—CXCL8—lung cancer	6.56e-05	0.000805	CbGpPWpGaD
Amcinonide—Dermatitis—Doxorubicin—lung cancer	6.53e-05	0.00165	CcSEcCtD
Amcinonide—NR3C1—Gene Expression—DICER1—lung cancer	6.52e-05	0.0008	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—JUNB—lung cancer	6.51e-05	0.000798	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—PIK3CG—lung cancer	6.31e-05	0.000774	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—CASP3—lung cancer	6.28e-05	0.00077	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—IL6—lung cancer	6.17e-05	0.000756	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—PIK3CD—lung cancer	6.11e-05	0.00075	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—STAT3—lung cancer	6.11e-05	0.000749	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—JUN—lung cancer	6.1e-05	0.000748	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—POMC—lung cancer	6.01e-05	0.000737	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—STK11—lung cancer	5.91e-05	0.000725	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—IL6R—lung cancer	5.86e-05	0.000719	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—lung cancer	5.75e-05	0.000705	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—FOXO3—lung cancer	5.7e-05	0.000699	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—AKT1—lung cancer	5.69e-05	0.000698	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—SKI—lung cancer	5.63e-05	0.000691	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—EP300—lung cancer	5.63e-05	0.00069	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—MAP2K1—lung cancer	5.59e-05	0.000685	CbGpPWpGaD
Amcinonide—Dexamethasone—PTGS2—lung cancer	5.56e-05	0.0264	CrCbGaD
Amcinonide—ANXA1—Signaling by GPCR—PIK3CD—lung cancer	5.55e-05	0.000681	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—AVP—lung cancer	5.34e-05	0.000655	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—VEGFA—lung cancer	5.33e-05	0.000654	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—PIK3CB—lung cancer	5.33e-05	0.000653	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—IGF1R—lung cancer	5.14e-05	0.000631	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—CXCL8—lung cancer	5.12e-05	0.000628	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—HES1—lung cancer	5.05e-05	0.00062	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—RAF1—lung cancer	4.96e-05	0.000608	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—IL2—lung cancer	4.89e-05	0.0006	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—PIK3CB—lung cancer	4.84e-05	0.000593	CbGpPWpGaD
Amcinonide—Dexamethasone—ABCB1—lung cancer	4.73e-05	0.0225	CrCbGaD
Amcinonide—ANXA1—Signaling by GPCR—CXCL8—lung cancer	4.65e-05	0.00057	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—ERBB3—lung cancer	4.62e-05	0.000566	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—RARB—lung cancer	4.52e-05	0.000555	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—IL2—lung cancer	4.44e-05	0.000545	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—TERT—lung cancer	4.43e-05	0.000543	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—NPPA—lung cancer	4.41e-05	0.00054	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—FGFR1—lung cancer	4.3e-05	0.000527	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—IL6—lung cancer	4.27e-05	0.000523	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—HIF1A—lung cancer	4.23e-05	0.000519	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—APOA1—lung cancer	4.09e-05	0.000501	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—KDR—lung cancer	4.05e-05	0.000497	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—HSPB1—lung cancer	3.79e-05	0.000465	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—APC—lung cancer	3.73e-05	0.000457	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—KIT—lung cancer	3.73e-05	0.000457	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PIK3CG—lung cancer	3.73e-05	0.000457	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—NRAS—lung cancer	3.73e-05	0.000457	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—EGF—lung cancer	3.69e-05	0.000452	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—IL6—lung cancer	3.69e-05	0.000452	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—MAPK3—lung cancer	3.57e-05	0.000438	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—POMC—lung cancer	3.55e-05	0.000435	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—BRAF—lung cancer	3.51e-05	0.00043	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—CREBBP—lung cancer	3.49e-05	0.000428	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—IL6R—lung cancer	3.46e-05	0.000425	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CREBBP—lung cancer	3.46e-05	0.000424	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—EGFR—lung cancer	3.4e-05	0.000417	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—NOTCH3—lung cancer	3.34e-05	0.00041	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—MAP2K1—lung cancer	3.3e-05	0.000405	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PIK3CD—lung cancer	3.28e-05	0.000402	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—PIK3CA—lung cancer	3.25e-05	0.000398	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—KRAS—lung cancer	3.21e-05	0.000394	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—JUNB—lung cancer	3.16e-05	0.000388	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—PIK3CA—lung cancer	2.95e-05	0.000362	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—MDM2—lung cancer	2.94e-05	0.00036	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—RAF1—lung cancer	2.93e-05	0.000359	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—ERBB2—lung cancer	2.9e-05	0.000355	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PIK3CB—lung cancer	2.86e-05	0.000351	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—MTOR—lung cancer	2.86e-05	0.000351	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CXCL8—lung cancer	2.75e-05	0.000337	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—HRAS—lung cancer	2.73e-05	0.000335	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—AKT1—lung cancer	2.65e-05	0.000325	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CASP3—lung cancer	2.63e-05	0.000322	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—IL2—lung cancer	2.62e-05	0.000322	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—IL6—lung cancer	2.61e-05	0.00032	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CCND1—lung cancer	2.56e-05	0.000314	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—JUN—lung cancer	2.55e-05	0.000313	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—MMP9—lung cancer	2.48e-05	0.000305	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CDKN1A—lung cancer	2.48e-05	0.000304	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PTEN—lung cancer	2.47e-05	0.000303	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—AKT1—lung cancer	2.41e-05	0.000295	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—EP300—lung cancer	2.36e-05	0.000289	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—ERCC2—lung cancer	2.3e-05	0.000282	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—SRC—lung cancer	2.29e-05	0.000281	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—VEGFA—lung cancer	2.23e-05	0.000274	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—STAT3—lung cancer	2.21e-05	0.000271	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—NRAS—lung cancer	2.2e-05	0.00027	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—MAPK3—lung cancer	2.11e-05	0.000259	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—MYC—lung cancer	2.07e-05	0.000254	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—MYC—lung cancer	2.05e-05	0.000252	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—EGFR—lung cancer	2.01e-05	0.000246	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—KRAS—lung cancer	1.9e-05	0.000233	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PIK3CA—lung cancer	1.74e-05	0.000214	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—TP53—lung cancer	1.69e-05	0.000207	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—CREBBP—lung cancer	1.68e-05	0.000206	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—HRAS—lung cancer	1.61e-05	0.000198	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—IL6—lung cancer	1.54e-05	0.000189	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—AKT1—lung cancer	1.42e-05	0.000175	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—MAPK3—lung cancer	1.03e-05	0.000126	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—MYC—lung cancer	9.98e-06	0.000122	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—AKT1—lung cancer	6.92e-06	8.48e-05	CbGpPWpGaD
